These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 6901589)
1. Patho-physiology of kallikrein system. Colman RW Ann Clin Lab Sci; 1980; 10(3):220-6. PubMed ID: 6901589 [TBL] [Abstract][Full Text] [Related]
2. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents. España F; Ratnoff OD J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770 [TBL] [Abstract][Full Text] [Related]
3. Role of the contact system in fibrinolysis. Kluft C; Dooijewaard G; Emeis JJ Semin Thromb Hemost; 1987 Jan; 13(1):50-68. PubMed ID: 3105061 [No Abstract] [Full Text] [Related]
4. The contact activation system: biochemistry and interactions of these surface-mediated defense reactions. Colman RW; Schmaier AH Crit Rev Oncol Hematol; 1986; 5(1):57-85. PubMed ID: 3633772 [TBL] [Abstract][Full Text] [Related]
5. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen. Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690 [TBL] [Abstract][Full Text] [Related]
6. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Kaplan AP Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144 [TBL] [Abstract][Full Text] [Related]
8. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein. Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899 [TBL] [Abstract][Full Text] [Related]